<TEXT>&#2;<DATELINE>2009-05-01</DATELINE><TITLE>New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors</TITLE><BODY>A series of trifluoromethyl, benzothiazolyl or thiazolyl ketone-containing peptidic compounds as SARS-CoV 3CL protease inhibitors were developed and their potency was evaluated by in vitro protease inhibitory assays. Three candidates had encouraging results for the development of new anti-SARS compounds.&#3;</BODY></TEXT>